---
figid: PMC6599664__thnov09p4308g008
figtitle: Schematic depicting the mechanisms of RCAN1.4 to prevent liver fibrosis
organisms:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Oryctolagus cuniculus
- Macaca mulatta
- Drosophila melanogaster
- Zea mays
- Adeno-associated virus
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
pmcid: PMC6599664
filename: thnov09p4308g008.jpg
figlink: /pmc/articles/PMC6599664/figure/F7/
number: F7
caption: Schematic depicting the mechanisms of RCAN1.4 to prevent liver fibrosis.
  RCAN1.4 was selectively downregulated in liver fibrosis mediated by DNMT1 and DNMT3b.
  Forced RCAN1.4 expression could alleviate liver injury, inhibit HSC activation,
  proliferation and promote activated HSC apoptosis through CaN/NFAT3 signaling pathway
  in vivo and in vitro. However, silencing of RCAN1.4 exacerbates liver fibrosis in
  vitro. In briefly, RCAN1.4 may serve as a potential therapeutic target in the treatment
  of liver fibrosis.
papertitle: Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate
  cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.
reftext: Xue-yin Pan, et al. Theranostics. 2019;9(15):4308-4323.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9548138
figid_alias: PMC6599664__F7
figtype: Figure
redirect_from: /figures/PMC6599664__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6599664__thnov09p4308g008.html
  '@type': Dataset
  description: Schematic depicting the mechanisms of RCAN1.4 to prevent liver fibrosis.
    RCAN1.4 was selectively downregulated in liver fibrosis mediated by DNMT1 and
    DNMT3b. Forced RCAN1.4 expression could alleviate liver injury, inhibit HSC activation,
    proliferation and promote activated HSC apoptosis through CaN/NFAT3 signaling
    pathway in vivo and in vitro. However, silencing of RCAN1.4 exacerbates liver
    fibrosis in vitro. In briefly, RCAN1.4 may serve as a potential therapeutic target
    in the treatment of liver fibrosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - cl
  - ci
  - dpp
  - gbb
  - put
  - mav
  - Edg84A
  - Mt2
  - Nmt
  - Vegfa
  - Nfatc4
  - Pfdn4
  - Oog1
  - Tgfb1
  - Ltbp1
  - Apc
  - Rb1cc1
  - Ceacam1
  - Dnmt1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IGF1
  - NFATC4
  - C1QA
  - C1QB
  - C1QC
  - C1R
  - C1S
  - TGFB1
  - TGFB2
  - TGFB3
  - CRYGC
  - CRYGEP
  - CCL1
  - CCL2
  - CCL3L1
  - CCL3L3
  - CCL4L1
  - CCL4L2
  - CCL5
  - CCL7
  - CCL8
  - CCL11
  - CCL13
  - CCL14
  - CCL15
  - CCL16
  - CCL17
  - CCL18
  - CCL19
  - CCL20
  - CCL21
  - CCL22
  - CCL24
  - CCL25
  - CCL26
  - CCL27
  - CCL28
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - CXCL9
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL16
  - CXCL17
  - XCL1
  - XCL2
  - CCL3
  - CCL4
  - RB1CC1
  - DNMT1
  - DNMT3A
  - DNMT3B
  - DNMT3L
  - CCl
  - CaN
  - Liver fibrosis
---
